Amy Wechsler

Amy Wechsler appears in our data through filings on Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) shares, published by SEDI. We count 3 filings; the first trade dates from 14 June 2016 and the latest from 26 May 2021.

Sales make up the whole of the open-market record (1 sale, €237k). Outside the open market, there are 1 option exercise. So far in 2021, the count stands at no purchases and 1 sale.

On 28 May 2021 came the latest disclosure, an open-market sale for €237k in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.